Home
>
National Drug Code (NDC)
>
Lansoprazole
Lansoprazole - 59726-019-14 - (Lansoprazole)
Drug Information of Lansoprazole
| Product NDC: | 59726-019 |
| Proprietary Name: | Lansoprazole |
| Non Proprietary Name: | Lansoprazole |
| Active Ingredient(s): | 15 mg/1 & nbsp; Lansoprazole |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, DELAYED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Lansoprazole
| Product NDC: | 59726-019 |
| Labeler Name: | P and L Development of New York Corporation |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | ANDA202727 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130115 |
Package Information of Lansoprazole
| Package NDC: | 59726-019-14 |
| Package Description: | 1 BOTTLE in 1 BOX (59726-019-14) > 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE |
NDC Information of Lansoprazole
| NDC Code | 59726-019-14 |
| Proprietary Name | Lansoprazole |
| Package Description | 1 BOTTLE in 1 BOX (59726-019-14) > 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE |
| Product NDC | 59726-019 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Lansoprazole |
| Dosage Form Name | CAPSULE, DELAYED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20130115 |
| Marketing Category Name | ANDA |
| Labeler Name | P and L Development of New York Corporation |
| Substance Name | LANSOPRAZOLE |
| Strength Number | 15 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |
